Results 171 to 180 of about 2,554,026 (187)

Gradual reduction of tophaceous deposits during urate-lowering therapy

Joint Bone Spine, 2021
Sara Nysom Christiansen, Lene Terslev, Mikkel Østergaard, Ole Slot   +3 more
openaire   +3 more sources

2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy

Joint Bone Spine, 2020
Augustin Latourte, Thomas Bardin, Tristan Pascart   +2 more
exaly  

Safety of Urate-Lowering Therapies

Rheumatic Disease Clinics of North America, 2012
openaire   +1 more source

Urate-Lowering Therapy Use among US Adults with Gout and the Relationship between Patients’ Gout Treatment Status and Associated Comorbidities

Rheumato, 2023
Youssef Roman, Alexandra Perez, Jeanlouis Betancourt-Gaztambide   +2 more
exaly  

Cardiovascular diseases in gout and urate-lowering therapy

Therapy, 2021
openaire   +1 more source

Palpable tophi and more comorbidities associated with adherence to urate-lowering medical therapy in a Chinese gout cohort

Joint Bone Spine, 2022
Robert Terkeltaub, Mingshu Sun
exaly  

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout

Frontiers in Medicine, 2020
Chii-Min Hwu, Chih-Cheng Hsu
exaly  

When to Start Urate Lowering Therapy?

Egyptian Journal of Rheumatology and Clinical Immunology, 2015
openaire   +1 more source

Urate-Lowering Therapy

2017
openaire   +1 more source

Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy

Nucleosides, Nucleotides and Nucleic Acids, 2008
Nancy Joseph-Ridge, Patricia A Macdonald   +1 more
exaly